openPR Logo
Press release

Merck & Co. Ordered to Pay Attorneys’ Fees, Costs Following VIOXX® Consumer Fraud Finding

06-19-2007 01:42 PM CET | Health & Medicine

Press release from: The Lanier Law Firm

ATLANTIC CITY, N.J. – New Jersey Superior Court judge Carol E. Higbee has ordered pharmaceutical giant Merck & Co. to pay fees and costs to a group of attorneys who proved in court that Merck committed fraud by deceiving doctors about the cardiovascular risks of the popular painkiller VIOXX® and deliberately hiding information about those risks from physicians.

Merck could have settled both consumer fraud claims for less than $5,000, but fought the allegations in an April 2006 trial. Similar consumer fraud claims are pending in thousands of additional cases against Merck.

Following the trial, jurors awarded $13.5 million in compensatory and punitive damages to 77-year-old John McDarby, who suffered a heart attack after taking VIOXX® for four years. Jurors also agreed that Merck committed consumer fraud and awarded an additional $4,013.36 to Mr. McDarby and $45 to second victim Thomas Cona based on the cost of their prescriptions.

The order signed June 15 awards approximately $4 million in fees and costs for the attorneys who represented Mr. McDarby and Mr. Cona.

“It is a pity that Merck is forcing our nation’s court system to waste thousands of hours of time and millions of dollars to hear these fraud claims after a jury has already said the company committed fraud,” says lead attorney Mark Lanier of The Lanier Law Firm. “This is lawsuit abuse by Merck, plain and simple.”

The New Jersey Consumer Fraud Act provides for “reasonable attorneys’ fees, filing fees and reasonable costs of suit” to plaintiffs who prove a consumer fraud claim. The New Jersey statute does not limit counsel fees according to the amount of the original claim. According to the court, the law “provides an incentive to competent counsel to undertake high-risk cases and to represent victims of fraud who suffer relatively minor losses.”

The ruling notes that Merck spent $500 million defending Vioxx cases in 2006, and the company has reserved more than $850 million to defend future cases.

Prior to the ruling, Merck withdrew any objection to the amount of time expended by attorneys for the plaintiffs or the hourly rate charged by plaintiffs’ counsel. The company acknowledged in a court filing that Merck’s overall fees and costs “were at least as high as plaintiffs corresponding fees and costs.”

With offices in Houston and New York, The Lanier Law Firm is committed to addressing client concerns with effective and innovative solutions. The firm is composed of outstanding trial attorneys with decades of experience handling cases involving pharmaceutical liability, asbestos exposure, business fraud, serious personal injuries, product liability, and toxic exposure.

The Lanier Law Firm
www.lanierlawfirm.com

Houston Law Office
6810 FM 1960 West
Houston, Texas 77069
(713) 659-5200
(713) 659-2204 – Fax

New York Law Office
Lanier Law Firm, PLLC
Tower 56
126 East 56th Street, 6th Floor
New York, NY 10022
(212) 421-2800
(212) 421-2878 – Fax

Press contact:
Alan Bentrup
800-559-4534

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Merck & Co. Ordered to Pay Attorneys’ Fees, Costs Following VIOXX® Consumer Fraud Finding here

News-ID: 22495 • Views: 2433

More Releases from The Lanier Law Firm

The Lanier Law Firm Joins Lawsuit Against EA Sports over ‘NCAA Football’ Vid …
Mass tort lawyer of the year joins team representing former student-athlete HOUSTON – Noted courtroom attorney Mark Lanier of the The Lanier Law Firm has joined the trial team representing former Rutgers University quarterback Ryan Hart in a closely watched right-to-publicity lawsuit against video game publisher EA Sports. Mr. Hart is seeking compensation for the unapproved use of his likeness and physical description in a series of EA Sports’ popular “NCAA Football”
Former Houston Texans Punter Sues Over Injury Caused by Reliant Stadium Field
HOUSTON – A former punter for the National Football League’s Houston Texans has filed a state district court lawsuit against the owners and managers of Reliant Stadium based on claims that the stadium’s poor field conditions caused him to suffer a career-threatening leg injury. Brett Hartmann was the NFL’s leading rookie punter when the Texans played the Atlanta Falcons on Dec. 4, 2011. In the game’s closing moments, Mr. Hartmann was
East Texas Patent Infringement Lawsuits Target Google, Yahoo!, Others Over Cloud …
SHERMAN, Texas – The Lanier Law Firm is announcing a series of patent infringement lawsuits filed on behalf of Longview, Texas-based Titanide Ventures LLC against a group of companies accused of infringing patents covering cloud storage technology. The lawsuits are filed in the U.S. District Court for the Eastern District of Texas, Sherman Division, against Mountain View, Calif.-based Google Inc. (NASDAQ: GOOG), Sunnyvale, Calif.-based Yahoo! Inc. (NASDAQ: YHOO), Los Altos, Calif.-based
The Lanier Law Firm Leads National Conference on Asbestos Litigation
HOUSTON – Trial attorney Richard Meadow, who leads the New York office of The Lanier Law Firm, is serving as Co-Chair of an upcoming national conference on asbestos litigation. The law firm is one of the lead sponsors for “Trying an Asbestos Case – How to Get the ‘W’,” an informative program for the nation’s top asbestos attorneys taking place on Jan 25, 2011, at the Hub Cira Centre in Philadelphia.

All 5 Releases


More Releases for Merck

Global Conjunctivitis Market 2018 - Allergan.Inc, Merck, Novartis
Apex Market Reports, recently published a detailed market research study focused on the “Conjunctivitis Market” across the global, regional and country level. The report provides 360° analysis of “Conjunctivitis Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Conjunctivitis on the basis of
Global Ivermectin Market 2018 - MERCK, ENN, LAND
Apex Market Reports, recently published a detailed market research study focused on the “Ivermectin Market” across the global, regional and country level. The report provides 360° analysis of “Ivermectin Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Ivermectin on the basis of
Global Vasodilator Market 2017 : GSK, Merck, Sanofi
Vasodilator Market 2017 A market study based on the " Vasodilator Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Vasodilator Market 2017’. The research report analyses the historical as well as present performance of the worldwide Vasodilator industry, and makes predictions on the future status of Vasodilator market on the basis of this analysis. Get Free Sample Copy of Report Here : http://www.marketsnresearch.com/request-for-sample.html?repid=17548 Top Manufacturers
Anthrax Vaccines Market 2017- Merial, Merck, Zoetis
Apex Research, recently published a detailed market research study focused on the "Anthrax Vaccines Market" across the global, regional and country level. The report provides 360° analysis of "Anthrax Vaccines Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Anthrax Vaccines industry, and estimates the future trend of Anthrax Vaccines market on
Pneumonia Vaccine Market- GlaxoSmithKline, Pfizer, Merck
Global Pneumonia Vaccine Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Pneumonia Vaccine Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players:- GlaxoSmithKline Pfizer Merck Enquiry for buying report @ https://goo.gl/793aS1 The Global Pneumonia Vaccine report gives a thorough situation of the present and gauge Pneumonia Vaccine showcase procedures, improvement methodologies and development openings.
Serum Market 2017- Merck, Corning, Bovogen
Apex Research, recently published a detailed market research study focused on the "Serum Market" across the global, regional and country level. The report provides 360° analysis of "Serum Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Serum industry, and estimates the future trend of Serum market on the basis of